Skip to main content
. 2020 May 1;2020:5723485. doi: 10.1155/2020/5723485

Table 2.

Comparison of transaminases levels at baseline and 3-month follow-up in treatment and control groups.

Groups (n = 230) Baseline (IU/L) 3 month follow-up p value
Treatment group (n = 106) SGPT (IU/L) 73.1 ± 20.4 44.6 ± 34.2 <0.001
SGOT (IU/L) 60.2 ± 24.5 38.3 ± 20.8 <0.001

Control group (n = 124) SGPT (IU/L) 63.4 ± 15.1 55.8 ± 45.9 0.161
SGOT (IU/L) 46.8 ± 13.7 45.5 ± 30.9 0.728

Paired t-test. SGPT: serum glutamic pyruvic transaminase; SGOT: serum glutamic-oxaloacetic transaminase.